Signaturefd, LLC Clovis Oncology, Inc. Transaction History

Signaturefd, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$1.43 - $3.14 $278 - $612	-195 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$2.7 - $4.76 $388 - $685	144 Added 282.35%	195 $1,000
Q3 2021 Oct 28, 2021	SELL	$4.06 - $5.8 $860 - $1,229	-212 Reduced 80.61%	51 $0
Q2 2021 Jul 26, 2021	BUY	$5.02 - $7.05 $245 - $345	49 Added 22.9%	263 $2,000
Q4 2020 Feb 11, 2021	SELL	$4.13 - $6.41 $1,672 - $2,596	-405 Reduced 65.43%	214 $1,000
Q3 2020 Nov 03, 2020	SELL	$4.82 - $7.72 $631 - $1,011	-131 Reduced 17.47%	619 $4,000
Q2 2020 Jul 30, 2020	BUY	$5.69 - $9.69 $4,267 - $7,267	750 New	750 $5,000
Q3 2019 Oct 16, 2019	SELL	$3.93 - $15.35 $3 - $15	-1 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$12.81 - $25.67 $12 - $25	-1 Reduced 50.0%	1 $0
Q1 2019 May 09, 2019	BUY	$17.66 - $30.28 $35 - $60	2 New	2 $0

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.